This segment is led by a duopoly: Novo Nordisk's semaglutide (Ozempic for diabetes, Wegovy for obesity) and Eli Lilly's tirzepatide (Mounjaro for T2D, Zepbound for obesity and sleep apnea) together commanded 57.4% of the overall peptide therapy market in 2026 an extraordinary concentration in a USD 84.2 billion market
Methylcobalamin is generally more expensive
Impact of Epithalon on sleep and mental health The modern pace of life, stress, and exposure to blue light from screens devastate our natural circadian rhythm
Solubility: It is the preferred solvent for dissolving peptide structures, as it maintains the correct pH balance to prevent peptide degradation (denaturing) during the reconstitution process
Iron deficiency anemia Iron deficiency anemia is one of the most common types of anemia
L-arginine, a nitric-oxide precursor, produced a moderate pressure drop